BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16183527)

  • 1. Endocrine tumours of the gastrointestinal tract. Management of metastatic endocrine tumours.
    Plöckinger U; Wiedenmann B
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):553-76. PubMed ID: 16183527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of metastatic disease in patients with neuroendocrine tumors.
    Niederhuber JE; Fojo T
    Surg Oncol Clin N Am; 2006 Jul; 15(3):511-33, viii. PubMed ID: 16882495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options.
    Arnold R
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):491-505. PubMed ID: 16183523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine tumours of the gastrointestinal tract. Transplantation in the management of metastatic endocrine tumours.
    Pascher A; Klupp J; Neuhaus P
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):637-48. PubMed ID: 16183532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract.
    Klöppel G; Anlauf M
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):507-17. PubMed ID: 16183524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastroenteropancreatic neuroendocrine tumours (carcinoid tumours): definition, clinical aspects, diagnosis and therapy].
    Bodelier AG; Haak HR
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1868-72. PubMed ID: 16970007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroendocrine tumours of the gastrointestinal tract].
    Plöckinger U; Wiedenmann B
    Z Gastroenterol; 2004 Jun; 42(6):517-27. PubMed ID: 15190448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours.
    O'Toole D; Ruszniewski P
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):585-94. PubMed ID: 16183529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic neuroendocrine tumours.
    Alexakis N; Neoptolemos JP
    Best Pract Res Clin Gastroenterol; 2008; 22(1):183-205. PubMed ID: 18206821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
    Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
    Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine tumours of the gastrointestinal tract: Chemotherapy.
    Arnold R; Rinke A; Schmidt Ch; Hofbauer L
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):649-56. PubMed ID: 16183533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases.
    Norton JA
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):577-83. PubMed ID: 16183528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine tumours of the pancreas.
    Oberg K; Eriksson B
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):753-81. PubMed ID: 16253899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal oncology].
    Stiefelhagen P
    Internist (Berl); 2005 Feb; 46(2):216-25. PubMed ID: 15655683
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastrointestinal and pancreatic neuroendocrine tumours and carcinomas; a review of rare tumour type.
    Siddiqa A; Adel H; Khan SA; Huda F; Sattar A
    J Pak Med Assoc; 2019 Apr; 69(4):533-540. PubMed ID: 31000859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.
    Butturini G; Bettini R; Missiaglia E; Mantovani W; Dalai I; Capelli P; Ferdeghini M; Pederzoli P; Scarpa A; Falconi M
    Endocr Relat Cancer; 2006 Dec; 13(4):1213-21. PubMed ID: 17158766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects.
    Guillermet-Guibert J; Lahlou H; Pyronnet S; Bousquet C; Susini C
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):535-51. PubMed ID: 16183526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics.
    Rindi G; Bordi C
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):519-34. PubMed ID: 16183525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas.
    Koumarianou A; Chatzellis E; Boutzios G; Tsavaris N; Kaltsas G
    Endokrynol Pol; 2013; 64(1):60-72. PubMed ID: 23450449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.